Marcaine
Product Images NDC 0409-1582

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Marcaine (NDC 0409-1582). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Marcaine 01)

Chemical structure of Marcaine (bupivacaine), including a piperidine ring attached to an amide bond connected to a methylphenyl group, shown with hydrochloride and water of hydration components.*

FDA Label Image

Chemical Structure (Marcaine 02)

Chemical structure diagram depicting the active ingredient of Marcaine and its associated compound. The image shows two molecular structures side by side, representing the chemical composition related to this drug product by Hospira, Inc.*

FDA Label Image

Logo (Marcaine 03)

FDA Label Image

Principal Display Panel (25 mg/10 mL Vial Label)

Packaging label of Marcaine 0.25% (25 mg/10 mL) preservative-free single-dose vial. The label states the product contains 2.5 mg/mL bupivacaine hydrochloride and epinephrine injection, USP, with epinephrine 1:200,000 (as bitartrate). It is intended for infiltration, nerve block, caudal and epidural anesthesia, and is not for intrathecal anesthesia. Contains warnings about epinephrine, sulfites, storage instructions, and distributor information for Hospira, Inc.*

FDA Label Image

Principal Display Panel (25 mg/10 mL Vial Carton)

Marcaine 0.25% (25 mg/10 mL) preservative-free injection vial label by Hospira, Inc. Contains bupivacaine hydrochloride and epinephrine 1:200,000 (as bitartrate). Pack includes 10 single-dose 10 mL vials. The label highlights its use for infiltration, nerve block, caudal and epidural anesthesia but states it is not for intrathecal anesthesia. Warnings include the presence of sulfites and epinephrine.*

FDA Label Image

Principal Display Panel (75 mg/30 mL Vial Label)

Label for Marcaine 0.25% (75 mg/30 mL, 2.5 mg/mL) single dose vial by Hospira, Inc. The label indicates the product contains epinephrine 1:200,000 (as bitartrate), is preservative-free, and is intended for infiltration, nerve block, caudal, and epidural anesthesia. It is not for intrathecal anesthesia and warns of sulfite content. Includes dosing and storage instructions, lot and expiration placeholders, and a barcode.*

FDA Label Image

Principal Display Panel (75 mg/30 mL Vial Carton)

Packaging label for Marcaine 0.25% (75 mg/30 mL, 2.5 mg/mL) preservative-free injection with epinephrine 1:200,000 (as bitartrate) by Hospira, Inc. The label states it contains 30 mL in 10 single-dose vials and is indicated for infiltration, nerve block, caudal, and epidural anesthesia. It includes warnings for not using intrathecally and a sulfite warning.*

FDA Label Image

Principal Display Panel (50 mg/10 mL Vial Label)

Marcaine 0.5% (50 mg/10 mL) vial label from Hospira, Inc. The label indicates it is a preservative-free, single-dose vial for nerve block, caudal, and epidural anesthesia. It contains 5 mg/mL bupivacaine hydrochloride with epinephrine 1:200,000 as bitartrate. The vial warns about epinephrine content and sulfites and states it is not for intrathecal anesthesia.*

FDA Label Image

Principal Display Panel (50 mg/10 mL Vial Carton)

Packaging label for Marcaine 0.5% (5 mg/mL) preservative-free injection, 50 mg/10 mL vial with epinephrine 1:200,000 (as bitartrate). The label indicates the product is for nerve block, caudal, and epidural anesthesia and warns it is not for intrathecal anesthesia. Distributed by Hospira, Inc., the carton contains 10 single-dose vials.*

FDA Label Image

Principal Display Panel (150 mg/30 mL Vial Label)

Marcaine 0.5% (150 mg/30 mL) single dose vial label by Hospira, Inc. The vial is preservative-free, containing bupivacaine hydrochloride and epinephrine 1:200,000 (as bitartrate). It is indicated for nerve block, caudal, and epidural anesthesia but not for intrathecal anesthesia. The label includes warnings about sulfites and instructions to discard unused portions after initial use.*

FDA Label Image

Principal Display Panel (150 mg/30 mL Vial Carton)

Packaging label for Marcaine 0.5% (150 mg/30 mL, 5 mg/mL) preservative-free injection by Hospira, Inc. The product contains bupivacaine hydrochloride and epinephrine 1:200,000 (as bitartrate) for nerve block, caudal, and epidural anesthesia. The label emphasizes it is not for intrathecal anesthesia and contains a warning about sulfites. The package is a box containing 10 single-dose 30 mL vials.*

FDA Label Image

Principal Display Panel (125 mg/50 mL Vial Label)

Marcaine 0.25% (125 mg/50 mL) multiple-dose vial label. The product contains 2.5 mg/mL bupivacaine hydrochloride and 0.0091 mg/mL epinephrine bitartrate, indicated for infiltration and nerve block injection. The label highlights it is not for caudal, epidural, or intrathecal anesthesia and includes warnings about containing epinephrine and sulfites. Distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (125 mg/50 mL Vial Carton)

Packaging label for Marcaine 0.25% (125 mg/50 mL) Multiple-Dose Vial with epinephrine 1:200,000 (as bitartrate) by Hospira, Inc. The label includes dosage form and strength, active ingredients bupivacaine hydrochloride and epinephrine injection USP, storage instructions, and warnings including use for infiltration and nerve block, and contraindications for caudal, epidural, or intrathecal anesthesia.*

FDA Label Image

Principal Display Panel (250 mg/50 mL Vial Label)

Marcaine 0.5% 250 mg/50 mL (5 mg/mL) multiple-dose vial label featuring bupivacaine hydrochloride and epinephrine injection, USP, indicated for nerve block. The label highlights epinephrine concentration 1:200,000 as bitartrate, warnings against autoclaving and presence of sulfites, plus storage instructions and distributor information for Hospira, Inc.*

FDA Label Image

Principal Display Panel (250 mg/50 mL Vial Carton)

Marcaine 0.5% (250 mg/50 mL, 5 mg/mL) multiple-dose vial packaging label by Hospira, Inc. Includes red text indicating 'with epinephrine 1:200,000 (as bitartrate)', and product details such as active ingredients bupivacaine hydrochloride and epinephrine injection USP. Additional information notes preservatives, storage instructions, usage warnings, and barcode. The label is primarily white with green, red, and black text.*

FDA Label Image

Principal Display Panel (25 mg/10 mL Vial Label)

Label for Marcaine 0.25% (bupivacaine HCl injection, USP) 25 mg/10 mL single-dose vial. The preservative-free solution is for infiltration, nerve block, caudal, and epidural anesthesia. Distributed by Hospira, Inc., Lake Forest, IL. The label includes dosage instructions and storage conditions.*

FDA Label Image

Principal Display Panel (25 mg/10 mL Vial Tray)

Packaging label for Marcaine 0.25% (bupivacaine HCl injection, USP), 25 mg/10 mL (2.5 mg/mL) preservative-free solution. The carton contains 25 single-dose vials of 10 mL each and is labeled for infiltration, nerve block, caudal, and epidural anesthesia. Distributed by Hospira, Inc., made in Sweden. Includes NDC 0409-2510-25 and barcode.*

FDA Label Image

Principal Display Panel (75 mg/30 mL Vial Label)

Marcaine 0.25% bupivacaine HCl injection, USP 75 mg/30 mL (2.5 mg/mL) single-dose vial label. The vial contains 30 mL of preservative-free solution intended for infiltration, nerve block, caudal, and epidural anesthesia. Distributed by Hospira, Inc., Lake Forest, IL. Includes dosing instructions and storage conditions.*

FDA Label Image

Principal Display Panel (75 mg/30 mL Vial Label)

Label for Marcaine 0.25% (bupivacaine HCl injection, USP) 75 mg/30 mL (2.5 mg/mL) in 30 mL single-dose vials. The label states it is preservative free and intended for infiltration, nerve block, caudal, and epidural anesthesia, but not for intrathecal anesthesia. Manufactured by Hospira, Inc., the box contains 25 vials with NDC 0409-7535-25.*

FDA Label Image

Principal Display Panel (125 mg/50 mL Vial Label)

Label for Marcaine 0.25% (bupivacaine HCl injection, USP) 125 mg/50 mL in a 50 mL multiple-dose vial. The label includes drug concentration details, preservative information, and instructions noting the product is for infiltration and nerve block, but not for caudal, epidural, or intrathecal anesthesia. Distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (125 mg/50 mL Vial Tray)

Packaging label for Marcaine 0.25% bupivacaine HCl injection, USP 125 mg/50 mL (2.5 mg/mL) in a 50 mL multiple-dose vial. The label states the product is for infiltration and nerve block, distributed by Hospira, Inc. It includes handling instructions and the NDC 0409-1250-25.*

FDA Label Image

Principal Display Panel (50 mg/10 mL Vial Label)

Label for Marcaine 0.5% (bupivacaine HCl injection, USP) 50 mg/10 mL (5 mg/mL) single-dose vial. The preservative-free solution is manufactured by Hospira, Inc. The label indicates use for nerve block, caudal, and epidural anesthesia, with an explicit warning that it is not for intrathecal anesthesia.*

FDA Label Image

Principal Display Panel (50 mg/10 mL Vial Tray)

Packaging label for Marcaine 0.5% (bupivacaine HCl injection, USP) in a preservative-free 10 mL vial. The label indicates 50 mg/10 mL (5 mg/mL) strength, with 25 single-dose vials per package. It is labeled for nerve block, caudal, and epidural anesthesia, not for intrathecal anesthesia. Manufactured and distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (150 mg/30 mL Vial Label)

Marcaine 0.5% (bupivacaine HCl) injection, USP 150 mg/30 mL (5 mg/mL) single-dose vial label. Preservative-free solution for nerve block, caudal, and epidural anesthesia; not for intrathecal anesthesia. Produced by Hospira, Inc. with dosage details and storage instructions included.*

FDA Label Image

Principal Display Panel (150 mg/30 mL Vial Tray)

Packaging label for Marcaine 0.5% bupivacaine HCl injection, USP, 150 mg/30 mL (5 mg/mL) in a 30 mL vial. The label indicates it is for nerve block, caudal, and epidural anesthesia, not for intrathecal anesthesia. It contains 25 single-dose vials, preservative free, labeled by Hospira, Inc., made in Sweden.*

FDA Label Image

Principal Display Panel (250 mg/50 mL Vial Label)

Marcaine 0.5% bupivacaine HCl injection USP, 250 mg per 50 mL (5 mg/mL) in a 50 mL multiple-dose vial. The label states this vial contains bupivacaine HCl with methylparaben and NaCl in Water for Injection, pH adjusted with NaOH or HCl. Distributed by Hospira, Inc. The label includes storage instructions and warnings against use for caudal, epidural, or intrathecal anesthesia.*

FDA Label Image

Principal Display Panel (250 mg/50 mL Vial Tray)

Packaging label for Marcaine 0.5% (bupivacaine HCl injection, USP) 250 mg/50 mL (5 mg/mL) in a 50 mL multiple-dose vial. The label states it is for nerve block use and not for caudal, epidural, or intrathecal anesthesia. Distributed by Hospira, Inc., the label includes NDC numbers and storage instructions.*

FDA Label Image

Principal Display Panel (75 mg/10 mL Vial Label)

Label for Marcaine 0.75% (bupivacaine HCl injection, USP) 75 mg/10 mL single-dose vial. The label states preservative-free, intended for epidural and retrobulbar anesthesia use, with a warning against obstetric or intrathecal anesthesia. Distributed by Hospira, Inc., Lake Forest, IL, USA.*

FDA Label Image

Principal Display Panel (75 mg/10 mL Vial Tray)

Packaging label for Marcaine 0.75% (bupivacaine HCl injection, USP) 75 mg/10 mL single-dose vials. The label indicates preservative-free solution in 10 mL vials, with 25 vials per package. Distributed by Hospira, Inc., the label includes storage instructions and a barcode with NDC 0409-7510-25, stating use for epidural and retrobulbar anesthesia only.*

FDA Label Image

Principal Display Panel (225 mg/30 mL Vial Label)

Label for Marcaine 0.75% bupivacaine HCl injection, USP 225 mg/30 mL (7.5 mg/mL) single-dose vial, preservative free. Indicated for epidural and retrobulbar anesthesia with warnings against obstetric or intrathecal use. Label includes dosage form, strength, manufacturer Hospira, Inc., storage instructions, and a barcode.*

FDA Label Image

Principal Display Panel (225 mg/30 mL Vial Tray)

Packaging label for Marcaine 0.75% bupivacaine HCl injection, USP, 225 mg/30 mL (7.5 mg/mL) in a 30 mL vial. The label indicates it is preservative-free and intended for epidural and retrobulbar anesthesia, not for obstetric or intrathecal anesthesia. The product is labeled by Hospira, Inc., and the NDC is 0409-2253-25.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.